|
Quotes & Info
|
| CMN > SEC Filings for CMN > Form 8-K on 23-Jan-2009 | All Recent SEC Filings |
23-Jan-2009
Change in Directors or Principal Officers
(b) At a meeting of the Board of Directors of Cantel Medical Corp. (the "Company") held on October 22, 2008, Mr. Darwin Dornbush, a director of the Company since 1963, indicated that he desired not to stand for re-election at the next Annual Meeting of Stockholders. Therefore, the Board did not re-nominate Mr. Dornbush as a director and his term of office expired at the Annual Meeting of Stockholders held on January 8, 2009.
(e) At the Annual Meeting of Stockholders held on January 8, 2009, the Company's stockholders approved an amendment to the Cantel Medical Corp. 2006 Equity Incentive Plan (the "Plan") to increase by 700,000 the number of shares of common stock available for issuance under the Plan. The additional shares were authorized for issuance pursuant to stock options and stock appreciation rights. As amended, the maximum number of shares that may be issued under the Plan increased from 1,000,000 to 1,700,000 shares, with (i) the number of shares being authorized for issuance pursuant to stock options and stock appreciation rights being increased from 500,000 to 1,200,000 and (ii) 500,000 shares remaining authorized for issuance pursuant to restricted stock awards and performance awards (inclusive of prior awards under the Plan).
|
|